Key result
INPP5K c.67G>A variant linked to congenital muscular dystrophy with short stature and intellectual disability.
Case Report (n=4)
Identifies a recurrent pathogenic variant (c.67G>A) in INPP5K causing congenital muscular dystrophy with a founder effect in Southern Italy.
Supports targeted testing in Southern Italian congenital muscular dystrophy families; leaves open validation of prevalence and pathogenicity.
Inositol polyphosphate-5-phosphatase K (INPP5K [MIM: 607875]) acts as a PIP3 5-phosphatase and regulates actin cytoskeleton, insulin and cell migration. Biallelic pathogenic variants in INPP5K have recently been reported in patients affected by a form of muscular dystrophy with childhood-onset. Affected patients have limb girdle muscle weakness, often associated with bilateral cataracts, short stature, and intellectual disability. Here we report four patients affected by INPP5K-related muscle dystrophy, who were apparently unrelated but originated from the same geographical area in South Italy. These patients manifest a recognizable phenotype characterized by early onset muscular dystrophy associated to short stature and intellectual disability. All affected subjects were homozygous or compound heterozygous for the c.67G>A (p.Val23Met) missense change and shared a common haplotype, indicating the occurrence of a founder effect.
No takes yet. Share an insight, caveat, or question.
D’Amico et al. (2020) conducted a case report in INPP5K-related congenital muscular dystrophy (n=4). INPP5K c.67G>A (p.Val23Met) variant was evaluated on Clinical and genetic characterization. The INPP5K c.67G>A (p.Val23Met) variant underlies a recognizable phenotype of congenital muscular dystrophy with short stature and intellectual disability, demonstrating a founder effect in Southern Italy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: